Global Glutathione for Injection Market Growth 2023-2029

Global Glutathione for Injection Market Growth 2023-2029

The global Glutathione for Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Glutathione for Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Glutathione for Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Glutathione for Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Glutathione for Injection players cover Takeda, Biomedica Foscama, Zhejiang Hisun Pharmaceutical Co.Ltd., Luoxin Pharmaceuticals Group Stock Co.,ltd., Shandong Lvye Pharmaceutical Co.,Ltd., Kunming Jida Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd., Yaopharma Co., Ltd. and Shenyang Shuangding Pharmaceutical Co.,Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Glutathione is composed of glutamic acid, cysteine ​​and glycine, a tripeptide containing sulfhydryl groups, which has anti-oxidation and integrated detoxification effects, so glutathione, especially glutathione in liver cells, can participate in Biotransformation, thereby converting harmful poisons in the body into harmless substances, excreted out of the body, glutathione can also help maintain normal immune system functions. Due to the detoxification and antioxidant capacity of glutathione itself, glutathione has an important hepatoprotective effect, so reduced glutathione is clinically used as an important hepatoprotective drug.

LPI (LP Information)' newest research report, the “Glutathione for Injection Industry Forecast” looks at past sales and reviews total world Glutathione for Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Glutathione for Injection sales for 2023 through 2029. With Glutathione for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glutathione for Injection industry.

This Insight Report provides a comprehensive analysis of the global Glutathione for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glutathione for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Glutathione for Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glutathione for Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glutathione for Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Glutathione for Injection market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
0.3g/piece
0.6g/piece
1.2g/piece

Segmentation by application
Hospital
Clinic
Nursing Center
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Takeda
Biomedica Foscama
Zhejiang Hisun Pharmaceutical Co.Ltd.
Luoxin Pharmaceuticals Group Stock Co.,ltd.
Shandong Lvye Pharmaceutical Co.,Ltd.
Kunming Jida Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Mingxing Pharmaceutical Co.,Ltd.
Yaopharma Co., Ltd.
Shenyang Shuangding Pharmaceutical Co.,Ltd.
Hainan Zhuotai Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co.,Ltd.
Shanghai Fudan Forward Pharmaceutical Co.,Ltd.
Hangzhou Ausia Biological Technology Company,Ltd

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glutathione for Injection market?

What factors are driving Glutathione for Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glutathione for Injection market opportunities vary by end market size?

How does Glutathione for Injection break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.